SCHEDULE 13D/A

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, $0.001 par value · CUSIP: 76152G100

Event date: 2024-12-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Vedanta Associates-R, LPReported CIK 0001865703

  Shares: 1,967,768.00 · Class: 4.1%

• Vedanta Associates, L.P.Reported CIK 0001502222

  Shares: 3,408,401.00 · Class: 6.9%

• Beta Operators Fund, L.P.Reported CIK 0001614642

  Shares: 2,138,130.00 · Class: 4.4%

• VEDANTA PARTNERS, LLCReported CIK 0001502216

  Shares: 5,376,169.00 · Class: 10.6%

• Parag SaxenaReported CIK 0001015823

  Shares: 6,268,906.00 · Class: 12.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.